Location: Intercontinental Ballroom
Supported By: Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Program Details

Pulmonary arterial hypertension (PAH) is a chronic and life-changing progressive disease that, when left untreated, can lead to heart failure and death. Despite treatment advances and an increase in survival by more than 2-fold during the last 2 decades, PAH remains a fatal disease.

When should you suspect PAH in your patients? How would you go about accurately diagnosing PAH? What treatment options are there once you establish a diagnosis? How often should you be following up with your patients, and why?

Join our panel of experts for an engaging educational talk show and receive the tools you need to improve outcomes in your patients with PAH.

www.medscape.org/sympo/pah-talkshow

Speakers

Panelist: Lana Melendres-Groves, MD
University of New Mexico
Professor of Medicine University of New Mexico Assistant Dean
Albuquerque, New Mexico

Panelist: Namita Sood, MD, FCCP
University of California -Davis
Director UC Davis Advanced Lung Disease Program
Sacramento, California

Chair: Jean M Elwing, MD
University of Cincinnati
Professor of Medicine
Cincinnati, Ohio

Panelist: Ioana R. Preston, MD
Lahey Hospital and Medical Center
Director Pulmonary Hypertension Center
Burlington, Massachusetts

Virtual Chair: Brandon Jakubowski, MD
UT Southwestern Medical Center
Department of Internal Medicine
Assistant Professor
Dallas, Texas